Valuation: Certara, Inc.

Market Cap 1.08B 942M 869M 801M 1.51B 104B 1.54B 10.39B 4.09B 50.85B 4.05B 3.96B 175B P/E 2026 *
-69.3x
P/E 2027 * -693x
Enterprise Value 1.15B 1.01B 930M 857M 1.62B 111B 1.65B 11.11B 4.37B 54.37B 4.33B 4.23B 187B EV / Sales 2026 *
2.89x
EV / Sales 2027 * 2.62x
Free-Float
69.31%
Yield 2026 *
-
Yield 2027 * -
1 day-4.81%
1 week+2.36%
Current month+5.80%
1 month+14.93%
3 months+11.41%
6 months-27.13%
Current year-21.34%
1 week 6.52
Extreme 6.52
7.4
1 month 5.3
Extreme 5.305
7.4
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
President 62 01/08/2023
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap.
6/1/26 A Fiscal year

Head of Human Resources

16,535 0.0106%
6/1/26 A Fiscal year

General Counsel

57,763 0.0371%
5/14/26 A Fiscal year

Director

64,736 0.0422%
Change 5-day change 1-year change 3-year change Capi.($)
-4.81%+2.36%-34.25%-64.55% 1.08B
-1.82%+2.26%-23.04%+13.91% 2,925B
-1.53%+4.41%-14.03%+660.80% 317B
-6.93%-14.96%+204.60%+786.10% 110B
-9.47%-14.07%+2.88%+35.05% 91.05B
-1.38%+0.45%+80.71%+129.40% 92.08B
-7.85%-13.74%-34.76%-16.68% 73.58B
-2.04%-6.38%-37.72%+65.84% 63.73B
-1.21%-2.68%+1.18%+54.99% 43.94B
-4.31%-6.63%-57.70%+16.24% 37B
Average -3.50%-4.62%+8.79%+168.11% 375.56B
Weighted average by Cap. -0.09%+2.54%-12.96%+95.37%

Financials

2026 *2027 *
Net sales 399M 348M 321M 296M 558M 38.39B 571M 3.84B 1.51B 18.8B 1.5B 1.46B 64.72B 405M 354M 327M 301M 568M 39.05B 581M 3.91B 1.54B 19.12B 1.52B 1.49B 65.83B
Net income -16.86M -14.73M -13.59M -12.53M -23.62M -1.62B -24.14M -162M -63.91M -795M -63.31M -61.92M -2.74B -2.39M -2.09M -1.93M -1.77M -3.35M -230M -3.42M -23.02M -9.05M -113M -8.97M -8.77M -388M
Net Debt 74.77M 65.34M 60.3M 55.58M 105M 7.2B 107M 721M 283M 3.53B 281M 275M 12.14B -17.2M -15.03M -13.87M -12.78M -24.09M -1.66B -24.63M -166M -65.2M -811M -64.59M -63.17M -2.79B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
17/07/26 $6.930 -4.81% 2,140,868
16/07/26 $7.280 +3.12% 4,635,968
15/07/26 $7.060 +5.85% 2,593,526
14/07/26 $6.670 -1.77% 2,220,047
13/07/26 $6.790 +0.30% 1,973,526
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
6.930USD
Average target price
7.530USD
Spread / Average Target
+8.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock